Moreover, since upregulation of PLAU levels is also frequently observed in a number of malignancies and upregulation of PLAU is a prognostic marker not only in pancreatic cancer but also in head and neck, endometrial cancer, renal and lung (42), breast (140) and oesophageal cancer (27). The gene discussed is PLAU; the disease is pancreatic neoplasm.